Vitamin C reduces cortisol suppressant effect of etomidate in trauma patients undergoing RSI

When trauma victims experience Rapid Sequence Intubation (RSI), etomidate can lower their cortisol levels. Vitamin C supplementation reduces cortisol suppressant effect of etomidate in trauma patients undergoing RSI, according to a new study.

The study has been published in BMC Anesthesiology. 

The usual procedure for airway care and intubation in the emergency room is rapid sequence induction/intubation (ED). By utilizing an anesthetic medication and a neuro-muscular blocking agent, this approach can lower the chance of aspiration and intubation failure. Etomidate is a common induction agent for RSI in EDs and is an imidazole derivative. Due to this medication's rapid start of action, safe hemodynamic profile, low histamine generation, and limited impact on respiratory depression, it was chosen as a therapy for RSI. There are some reservations concerning its suppressive effects on the adreno-cortical axis, despite the fact that it has a safe hemodynamic profile. Antioxidants like vitamin C can offer protection in this situation. Therefore, to find out how vitamin C affects cortisol levels in trauma patients who undergo RSI with etomidate, Jafar Rahimi Panahi and crew undertook this clinical experiment.

The researchers looked at adult trauma patients who need RSI with etomidate in a controlled clinical study. Three hours after the RSI with etomidate in one group, cortisol levels were assessed. In the second group, we gave one gram of vitamin C before giving etomidate, and three hours later we assessed the cortisol level.

The key findings of this study were:

51 patients have been examined. 

After RSI with etomidate, the blood cortisol level was considerably reduced in both groups.